» Articles » PMID: 8862564

Use of Multiple PCR Primer Sets for Optimal Detection of Human Papillomavirus

Overview
Specialty Microbiology
Date 1996 Sep 1
PMID 8862564
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Using multiple PCR primer sets, we tried to optimize the detection of human papillomavirus (HPV) in DNA samples isolated from 361 frozen biopsy specimens from patients with invasive cervical carcinomas. The HPVs detected were placed into three distinct groups, including group I/Inex at Telelab (Skien, Norway) and group Ineg and group II at the Norwegian Radium Hospital (Oslo, Norway). The consensus primer sets were Oli-1b-oli-2i, My09-My11, Gp5-Gp6, and Gp(5+)-Gp6+ from the HPV L1 gene and CpI-CpIIG from the E1 gene. Using these consensus primers together with the type-specific primers from E6-E7, we found that 355 patients (98%) were HPV positive. Type-specific primers for HPV types 11, 16, 18, 31, 33, and 35 detected more HPV-infected patients than the most sensitive consensus primer set, while the three consensus primer sets My, Gp/Gp+, and Cp together detected more HPV-positive patients than the type-specific primers. Testing of sensitivity of the PCR with SiHa cells serially diluted in lymphocytes (HPV-negative cells) indicated a detection limit of 6,300 HPV type 16 DNA copies with consensus primers (My, Gp+, and Cp) and 126 original HPV type 16 DNA copies with type-specific primers. Comparison of the amplification results for consensus L1 primers and type-specific E6-E7 primers indicated the presence of L1 deletions in 23 of 56 samples. The conclusion is that in PCR detection systems, multiple consensus primers and type-specific primers should be used in order to detect all patients harboring HPV.

Citing Articles

Robust HPV-16 Detection Workflow for Formalin-Fixed Cancer Tissue and Its Application for Oral Squamous Cell Carcinoma.

Morodomi S, Hirosue A, Rahman A, Nohata K, Matsuo M, Reda O Cancer Med. 2025; 14(4):e70544.

PMID: 39980140 PMC: 11842277. DOI: 10.1002/cam4.70544.


Molecular Characterization of Bovine in Equine Sarcoids in Egypt.

Sobhy N, Refaai W, Kumar R, Bottros Youssef C, Goyal S Vet Med Int. 2025; 2025:9773642.

PMID: 39803352 PMC: 11724032. DOI: 10.1155/vmi/9773642.


Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens.

Qin L, Li D, Wang Z, Lan J, Han C, Mei J Front Public Health. 2024; 12:1421774.

PMID: 39100946 PMC: 11294082. DOI: 10.3389/fpubh.2024.1421774.


Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.

Fu Y, Li X, Li Y, Lu W, Xie X, Wang X Microbiol Spectr. 2022; 10(1):e0157021.

PMID: 35171029 PMC: 8849094. DOI: 10.1128/spectrum.01570-21.


Nested PCR followed by NGS: Validation and application for HPV genotyping of Tunisian cervical samples.

Ardhaoui M, Ennaifer E, Salim A, Gomez F, Laasili T, Boubaker M PLoS One. 2021; 16(8):e0255914.

PMID: 34379683 PMC: 8357094. DOI: 10.1371/journal.pone.0255914.


References
1.
ter Meulen J, Eberhardt H, Luande J, Mgaya H, Chang-Claude J, Mtiro H . Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa. Int J Cancer. 1992; 51(4):515-21. DOI: 10.1002/ijc.2910510403. View

2.
Romanczuk H, Howley P . Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A. 1992; 89(7):3159-63. PMC: 48824. DOI: 10.1073/pnas.89.7.3159. View

3.
Munoz N, Bosch F, de Sanjose S, Tafur L, Izarzugaza I, Gili M . The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992; 52(5):743-9. DOI: 10.1002/ijc.2910520513. View

4.
Guerrero E, Daniel R, Bosch F, Castellsague X, Munoz N, Gili M . Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol. 1992; 30(11):2951-9. PMC: 270559. DOI: 10.1128/jcm.30.11.2951-2959.1992. View

5.
DeBritton R, Hildesheim A, De Lao S, Brinton L, Sathya P, REEVES W . Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol. 1993; 81(1):19-24. View